A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist
Maja Payrits(University of Pecs), Éva Szőke(University of Pecs), Zsolt Sándor(Eötvös Loránd University), Péter Mátyus(Semmelweis University), Ruth Deme(Semmelweis University), Éva Sághy(University of Pecs), Róbert Ludmerczki(Semmelweis University), Andrea Czompa(Semmelweis University), Zsuzsanna Helyes(Hungarian Research Network)
Cited by 31
Related Papers
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
|Neurobiology of Disease|2011|178
Herbal remedies of Solidago—correlation of phytochemical characteristics and antioxidative properties
|Journal of Pharmaceutical and Biomedical Analysis|2003|152
In vitro antioxidant properties of Helichrysum arenarium (L.) Moench
|Journal of Ethnopharmacology|2000|116
The in vitro effect of Helichrysi flos on microsomal lipid peroxidation
|Journal of Ethnopharmacology|2001|109
Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line
|European Journal of Pharmacology|2009|104